-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
;. C2rShandong Tianli Pharmaceutical General Manager Wang Xinxin interview with the mass network
C2ra few days ago, Shandong Province to fully launch the new and old kinetic energy conversion major project mobilization conference held, blowing the Shandong industry-wide to high-quality development of the storm. New major historical opportunities call for new missions to take on. New and old kinetic energy conversion, enterprise is an indispensable subject. A team of reporters from The Mass Network came to Shouguang City, Shandong Tianli Pharmaceutical Co., Ltd. for an interview to explore how it has leapt from a small company to become Asia's largest sugar alcohol producer, a number of the world's top 500 enterprises suppliers, and products exported to more than 20 countries and regions.
C2r .Perfect ingestion industry chain two products the world's first
C2rapproached the production plant of Shandong Tianli Pharmaceuticals, the eyes are well-distributed, misplaced office buildings and factories. In the technologically advanced sorbitol production workshop, more than a dozen large cans are running, a hot scene. Volkswagen network reporter learned that Shandong Tianli Pharmaceutical Co., Ltd. was founded in 1994, shandong Union Chemical Group Co., Ltd. circular economy development products and extension, is the core subsidiary of the Group.
C2r .Wang Xinxin, general manager of Shandong Tianli Pharmaceutical Co., Ltd., said: "In the company's development of more than 20 years, Shandong Tianli Pharmaceuticals has been unremittingly changing." Through the deep understanding of the enterprise itself, planning the industrial layout, adjusting the sales policy, system full production, and comprehensively opening up the market, and achieved a good result of the simultaneous growth of sales prices and product sales. "
C2rAccording to Wang Xinxin, Shandong Tianli Pharmaceutical industry has reached an annual output of 500,000 tons of starch, 450,000 tons of sorbitol, 400,000 tons of glucose, 20,000 tons of glycol, 20,000 tons of vitamin C, 3000 tons of vitamin C sodium, 5000 tons of vitamin C phosphate esters. Among them, sorbitol, glycol in China's market share reached 50% and 60%, respectively, these two products in terms of production and the famous French Rogate company ranked first in the world.
C2r ."At present, Shandong Tianli Pharmaceutical sision pharmaceutical industry is the first corn deep processing enterprise with a complete industrial chain from corn starch to glucose, to sorbitol, glycol, to vitamin C and its deep-processed products, is asia's largest sugar alcohol producer, the world's future vitamin C industry backbone." Wang said.
C2r
to enhance product competitiveness and establish strategic cooperative relations with multinational countries
C2ras the star product of Shandong Tianli Pharmaceuticals, Wang Xinxin knows that the production and sales of glycol will directly affect the competitiveness and development space of enterprises. "Equipment is the key to production. We continue to strengthen management and assessment, do a good job of equipment maintenance, so that it maximizes efficiency. Strict inspection of equipment running drip, the leakage point control in place, eliminate hidden dangers, to ensure the normal supply of spare parts, minimize the impact of equipment on production. Wang Xinxin told the mass-network reporter.
C2r ."The company continues to optimize and upgrade the product technology, improve product competitiveness. At present, the chemical isomer and enzyme isomer position of glycol is running well, the conversion rate of glycosatose and fructose is improved, and the content of glycol in alcohol is further improved. Three crystallization process control, small grain, sieve material significantly reduced, glycol yield increased by 1.3% year-on-year. Wang said, "At the same time, the company strengthened the basic management of the workshop, put an end to the equipment empty operation, long flowing water, long ming lights and other phenomena, employees energy saving and consumption awareness, electricity consumption indicators compared to last year reduced by 20kwh/t, in the current market conditions are good, the reduction of production costs for the company to win a greater profit margin." "
C2rmass network reporter learned that, because of the enterprise products in the competition with the industry has a clear advantage, Shandong Tianli Pharmaceutical sorbitol, glycol and other star products production and sales and export volume in the same industry enterprises ranked first. The company's various products not only occupy an important share of the domestic market, but also exported to Europe, the United States, Thailand, Vietnam, Nigeria, Egypt, Iran, Taiwan and other more than 20 countries and regions. With Mars, Procter and Gamble, Colgate, Kraft, Unilever and other Fortune 500 enterprises to establish a long-term strategic partnership.
C2r . C2r Shandong Tianli Pharmaceutical Laboratory for product technology research and development
C2r to participate in the formulation of national industry standards to master the industry voice
C2r Wang Xinxin know that enterprises want to become bigger and stronger, walk in the forefront of peers, must become industry rule-makers. Wang Xinxin told the mass network reporter, in 2015, Shandong Tianli Pharmaceuticals as the only glycol manufacturer stake in food additive D-glycol food safety national standards and sorbitol and sorbitol liquid food safety national standards. In 2016, the company participated in the formulation of the "Food Safety National Standard Food Additive D-Glycel Alcohol" (GB 1886.177-2016), "Food Safety National Standard sorbitol and sorbitol liquid" (GB 1886.187-2016) two national standards, by the National Health AndFamily Planning Commission, the General Administration of Food and Drug Administration successfully promulgated.
C2r . "In April 2017, the China Biofermentation Industry Association held the "Sorbitol Industry Green Factory Evaluation Code" and other 10 group standard-setting work start-up meeting and the first drafting meeting. Shandong Tianli Pharmaceuticals as the sorbitol industry leader unit, starch sugar industry team member unit attended the meeting. At the meeting, Shandong Tianli Pharmaceuticals gave full play to the leading position of the industry leader, for the "sorbitol industry green factory evaluation norms," sorbitol industry green product evaluation norms, starch sugar industry green factory evaluation norms, starch sugar industry green product evaluation norms" drafted played a positive role. Wang said proudly.
C2r . "National fermentation industry top ten", "China starch sugar top 20" enterprises, "provincial enterprise technology center", "national sorbitol research and testing technology center", "alcohol ether chemical clean production of national engineering joint laboratory" ... This one honor is more proof of Shandong Tianli Pharmaceuticals in the same industry leading position, master more industry voice.
the opportunity of the transformation of The
of C2r, focus on new materials and new pharmaceutical areas
C2r the industrial structure to replace the new "ticket" in order to board the high-quality development of the giant ship. In the severe economic situation, sub-segmentation of the sales market, adjust marketing strategy, through the improvement of degree, digging depth, breadth is the key to the success of enterprises in the market. Shandong Tianli Pharmaceuticals timely adjust the focus of work, into the short board industry, mining the depth of the market. "The food industry has always been a short-seller, with a relatively low market share and a majority of middlemen. In 2017, the company carried out a key planning and layout of the national food industry, selected some of the social visibility, good reputation, influence of food terminal customers to carry out key development, has passed Wangwang, hope, Daliyuan and other customers of the supplier audit, in order to expand the market share of the food industry has laid a good foundation. Wang said.
C2r . Wang said that through a series of transformationand and upgrading, enterprises will achieve sales revenue of 2.3 billion yuan in 2016, sales revenue in 2017 to 2.6 billion yuan, profits and taxes reached 380 million yuan. The competitiveness of the whole enterprise has risen to a new level.
C2r . "Next, Shandong Tianli Pharmaceuticals will focus on the production and development of vitamin products, new materials and new pharmaceutical technology breakthroughs and improvements. In May 2018, the company and the Chinese Academy of Sciences, as plasticizers for textile, plastic products production of isosyllol project will be completed and put into operation. At the same time, this year the company is also ready to invest 600 million yuan, the construction of new amino acids, methionine projects. For Shandong Tianli Pharmaceutical seine in new materials, new medicine, vitamins, amino acids and other aspects of the development of a good foundation. "
C2r
; . C2r Shandong Tianli Pharmaceutical General Manager Wang Xinxin interview with the mass network
C2r a few days ago, Shandong Province to fully launch the new and old kinetic energy conversion major project mobilization conference held, blowing the Shandong industry-wide to high-quality development of the storm. New major historical opportunities call for new missions to take on. New and old kinetic energy conversion, enterprise is an indispensable subject. A team of reporters from The Mass Network came to Shouguang City, Shandong Tianli Pharmaceutical Co., Ltd. for an interview to explore how it has leapt from a small company to become Asia's largest sugar alcohol producer, a number of the world's top 500 enterprises suppliers, and products exported to more than 20 countries and regions.
C2r . Perfect ingestion industry chain two products the world's first
C2r approached the production plant of Shandong Tianli Pharmaceuticals, the eyes are well-distributed, misplaced office buildings and factories. In the technologically advanced sorbitol production workshop, more than a dozen large cans are running, a hot scene. Volkswagen network reporter learned that Shandong Tianli Pharmaceutical Co., Ltd. was founded in 1994, shandong Union Chemical Group Co., Ltd. circular economy development products and extension, is the core subsidiary of the Group.
C2r . Wang Xinxin, general manager of Shandong Tianli Pharmaceutical Co., Ltd., said: "In the company's development of more than 20 years, Shandong Tianli Pharmaceuticals has been unremittingly changing." Through the deep understanding of the enterprise itself, planning the industrial layout, adjusting the sales policy, system full production, and comprehensively opening up the market, and achieved a good result of the simultaneous growth of sales prices and product sales. "
C2r According to Wang Xinxin, Shandong Tianli Pharmaceutical industry has reached an annual output of 500,000 tons of starch, 450,000 tons of sorbitol, 400,000 tons of glucose, 20,000 tons of glycol, 20,000 tons of vitamin C, 3000 tons of vitamin C sodium, 5000 tons of vitamin C phosphate esters. Among them, sorbitol, glycol in China's market share reached 50% and 60%, respectively, these two products in terms of production and the famous French Rogate company ranked first in the world.
C2r . "At present, Shandong Tianli Pharmaceutical sision pharmaceutical industry is the first corn deep processing enterprise with a complete industrial chain from corn starch to glucose, to sorbitol, glycol, to vitamin C and its deep-processed products, is asia's largest sugar alcohol producer, the world's future vitamin C industry backbone." Wang said.
C2r
to enhance product competitiveness and establish strategic cooperative relations with multinational countries
C2r as the star product of Shandong Tianli Pharmaceuticals, Wang Xinxin knows that the production and sales of glycol will directly affect the competitiveness and development space of enterprises. "Equipment is the key to production. We continue to strengthen management and assessment, do a good job of equipment maintenance, so that it maximizes efficiency. Strict inspection of equipment running drip, the leakage point control in place, eliminate hidden dangers, to ensure the normal supply of spare parts, minimize the impact of equipment on production. Wang Xinxin told the mass-network reporter.
C2r . "The company continues to optimize and upgrade the product technology, improve product competitiveness. At present, the chemical isomer and enzyme isomer position of glycol is running well, the conversion rate of glycosatose and fructose is improved, and the content of glycol in alcohol is further improved. Three crystallization process control, small grain, sieve material significantly reduced, glycol yield increased by 1.3% year-on-year. Wang said, "At the same time, the company strengthened the basic management of the workshop, put an end to the equipment empty operation, long flowing water, long ming lights and other phenomena, employees energy saving and consumption awareness, electricity consumption indicators compared to last year reduced by 20kwh/t, in the current market conditions are good, the reduction of production costs for the company to win a greater profit margin." "
C2r mass network reporter learned that, because of the enterprise products in the competition with the industry has a clear advantage, Shandong Tianli Pharmaceutical sorbitol, glycol and other star products production and sales and export volume in the same industry enterprises ranked first. The company's various products not only occupy an important share of the domestic market, but also exported to Europe, the United States, Thailand, Vietnam, Nigeria, Egypt, Iran, Taiwan and other more than 20 countries and regions. With Mars, Procter and Gamble, Colgate, Kraft, Unilever and other Fortune 500 enterprises to establish a long-term strategic partnership.
C2r . C2r Shandong Tianli Pharmaceutical Laboratory for product technology research and development
C2r to participate in the formulation of national industry standards to master the industry voice
C2r Wang Xinxin know that enterprises want to become bigger and stronger, walk in the forefront of peers, must become industry rule-makers. Wang Xinxin told the mass network reporter, in 2015, Shandong Tianli Pharmaceuticals as the only glycol manufacturer stake in food additive D-glycol food safety national standards and sorbitol and sorbitol liquid food safety national standards. In 2016, the company participated in the formulation of the "Food Safety National Standard Food Additive D-Glycel Alcohol" (GB 1886.177-2016), "Food Safety National Standard sorbitol and sorbitol liquid" (GB 1886.187-2016) two national standards, by the National Health AndFamily Planning Commission, the General Administration of Food and Drug Administration successfully promulgated.
C2r . "In April 2017, the China Biofermentation Industry Association held the "Sorbitol Industry Green Factory Evaluation Code" and other 10 group standard-setting work start-up meeting and the first drafting meeting. Shandong Tianli.